Cargando…
Antibody-mediated depletion of human CLEC-2 in a novel humanized mouse model
[Figure: see text]
Autores principales: | Brown, Helena C., Beck, Sarah, Navarro, Stefano, Di, Ying, Soriano Jerez, Eva M., Kaczmarzyk, Jana, Thomas, Steven G., Mirakaj, Valbona, Watson, Steve P., Nieswandt, Bernhard, Stegner, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027499/ https://www.ncbi.nlm.nih.gov/pubmed/36044387 http://dx.doi.org/10.1182/bloodadvances.2021006463 |
Ejemplares similares
-
Divalent nanobodies to platelet CLEC-2 can serve as agonists or antagonists
por: Clark, Joanne C., et al.
Publicado: (2023) -
The expression of mouse CLEC‐2 on leucocyte subsets varies according to their anatomical location and inflammatory state
por: Lowe, Kate L., et al.
Publicado: (2015) -
CLEC-2 Supports Platelet Aggregation in Mouse but not Human Blood at Arterial Shear
por: Bourne, Joshua H., et al.
Publicado: (2022) -
Rac Inhibition Causes Impaired GPVI Signalling in Human Platelets through GPVI Shedding and Reduction in PLCγ2 Phosphorylation
por: Neagoe, Raluca A. I., et al.
Publicado: (2022) -
Targeting of a Conserved Epitope in Mouse and Human GPVI Differently Affects Receptor Function
por: Navarro, Stefano, et al.
Publicado: (2022)